Pharmaceutical leaders must address four critical questions before implementing autonomous AI systems in their operations, according to industry guidance from Pharmaphorum. The article outlines essential considerations that executives should evaluate to ensure responsible AI deployment within the pharmaceutical sector. These questions focus on governance, risk management, and organizational readiness for AI-driven decision-making processes.
Search
